Return to homepagePandemic Pact

Study of the regulation of the type I interferon response in the control of SARS-Cov2 infection and its pathogenesis]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $244,000

  • Funder

    Other funders (France)

  • Principal Investigator

    Marlène DREUX

  • Research Location

    France

  • Lead Research Institution

    Centre International de Recherche en Infectiologie de Lyon

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The purpose of the IFN-COVID19 project is to explore how Sars-CoV-2 reacts to an anti-infectious molecule produced by the immune system: type I interferon. Currently being tested in clinical trials, the Interferon treatment could show promise in managing some forms of Covid-19.